Skip to main content
. 2015 Aug 12;102(4):881–890. doi: 10.3945/ajcn.115.113282

TABLE 1.

Characteristics of participants in the colorectal cancer data set by tertiles of fiber intake1

Tertiles of total fiber intake
Characteristic <9.9 g/1000 kcal ≥9.9 to <12.8 g/1000 kcal ≥12.8 g/1000 kcal P value
Age at baseline, y 61.6 ± 5.12 62.7 ± 5.3 63.7 ± 5.4 <0.001
Male sex, n (%) 12,685 (65.9) 9609 (49.9) 7511 (39.0) <0.001
Ethnicity, n (%) <0.001
 Non-Hispanic white 17,545 (91.1) 17,780 (92.3) 17,151 (89.1)
 Non-Hispanic black 790 (4.1) 602 (3.1) 821 (4.3)
 Asian 494 (2.6) 518 (2.7) 823 (4.3)
 Other 429 (2.2) 358 (1.9) 463 (2.4)
Education, n (%)
 College graduate or postgraduate 6091 (31.7) 7126 (37.0) 7604 (39.5) <0.001
BMI, kg/m2 28.0 ± 4.8 27.4 ± 4.8 26.6 ± 4.7 <0.001
Physical activity ≥4 h/wk, n (%) 3429 (17.8) 4246 (22.1) 5823 (30.2) <0.001
Smoking status, n (%) <0.001
 Never 6052 (31.4) 8544 (44.4) 10,062 (52.3)
 Former 3275 (17.0) 1494 (7.8) 904 (4.7)
 Current 8993 (46.7) 8414 (43.7) 7643 (39.7)
 Pipe or cigar smoker only 935 (4.9) 800 (4.2) 645 (3.4)
Alcohol intake, g/1000 kcal 8.1 ± 12.2 4.2 ± 6.9 2.5 ± 4.8 <0.001
Family history of colorectal cancer, n (%) 1919 (10.0) 2006 (10.5) 2062 (10.8) 0.14
Adenoma at T0 screen, n (%) 1989 (10.3) 1622 (8.4) 1316 (6.8) <0.001
Adenoma at T3/T5 screen, n (%) 2995 (15.5) 2410 (12.5) 1990 (10.3) <0.001
Ever regular NSAID use, n (%) 11,946 (62.0) 11,950 (62.1) 11,643 (60.5) 0.004
Total energy intake, kcal/d 2303.3 (891.7) 2028.3 (746.1) 1816.1 (662.6) <0.001
Dietary calcium intake, mg/1000 kcal 445.4 (182.0) 473.8 (157.1) 497.1 (152.0) <0.001
Supplemental calcium intake, mg/1000 kcal 111.5 (204.2) 167.1 (252.4) 229.4 (306.7) <0.001
Total folate intake, mg/1000 kcal 248.6 (175.4) 317.7 (192.9) 407.6 (236.7) <0.001
Red meat intake, g/1000 kcal 34.9 (20.9) 28.8 (16.6) 20.8 (14.0) <0.001
Processed meat intake, g/1000 kcal 11.3 (9.7) 8.01 (7.1) 5.1 (5.6) <0.001
Hormone replacement therapy, n (%)3 3308 (50.3) 5082 (52.67) 6019 (51.2) <0.001
1

n = 19,258 participants. NSAID, nonsteroidal anti-inflammatory drug; T0, baseline; T3/T5, year 3 or 5.

2

Mean ± SD (all such values).

3

In females only.